First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

[Image: see text] STARD3 is a cellular protein that represents an attractive target for cancer therapy, being overexpressed in breast cancer and implied in the development of colorectal, gastric, and prostate cancers. Unfortunately, no STARD3 inhibitor has been identified yet. In this work, an in si...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:ACS Med Chem Lett
Κύριοι συγγραφείς: Lapillo, Margherita, Salis, Barbara, Palazzolo, Stefano, Poli, Giulio, Granchi, Carlotta, Minutolo, Filippo, Rotondo, Rossella, Caligiuri, Isabella, Canzonieri, Vincenzo, Tuccinardi, Tiziano, Rizzolio, Flavio
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Chemical Society 2019
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466518/
https://ncbi.nlm.nih.gov/pubmed/30996782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00509
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια